

Cover Story
It appears that researchers needn’t venture far from home in search of animals that experience cancer much like we humans do.
In Brief
Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for March 2023
The National Cancer Institute approved the following clinical research studies last month. Â
Trending Stories
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- Trump cuts IVF drug deal with Merck in exchange for tariff exemption
- Science advocates organize march in DC to demand impeachment of RFK Jr.
- Friends study points to ctDNA’s potential to serve as an intermediate endpoint in NSCLC
ctMoniTR project aims to improve efficiency in development of intermediate endpoints - Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA















